InvestorNewsBreaks – Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) HealthTab(TM) Demonstrates New, Better Way of Doing Pharmacy Practice

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) earlier this year signed a master agreement with Canada’s largest pharmacy network, Shoppers Drug Mart, that would enable patients to access its HealthTab(TM) platform. HealthTab is an innovative point-of-care blood screening and health-data management platform – integrated with Abbott’s Afinion 2 analyzers. Notably, the small, fast and multi-assay analyzers provide valuable point-of-care testing to patients. Avricore then undertook a test rollout of its platform in which over 600 results were reported in the week-and-a-half trial period. A recent article reads, “Following the test rollout, a pharmacist and associate owner of a Shoppers Drug Mart located in Mississauga, Ontario, expressed his excitement at having HealthTab in his store because the platform would demonstrate a new, better way of doing pharmacy practice. ‘This is really profound because having access to lab-accurate results at our fingertips means we can better help family physicians by conducting regular follow up using advanced diagnostics with our diabetic and cardiovascular patients more effectively,’ Mohamed Adel Elsabakhawi had said.”

To view the full article, visit https://ibn.fm/tOZvS

Avricore Health is a pharmacy service innovator focused on acquiring and developing early stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab(TM) (a wholly owned subsidiary), its mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies. For more information about the company, visit www.AvricoreHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.